Postural Control in Covid-19

COVID-19 Clinical Trial

Official title:

Covid 19 and Postural Sway: A Comprasion of SARS-CoV-2 and Healthy Sedentary Women

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05299320
• Other study ID #: 12-2022/15
• Status: Completed
• Start date: March 2, 2022
• Est. completion date: June 20, 2022

Study information

• Verified date: July 2022
• Source: Karamanoglu Mehmetbey University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

This study was planned to investigate how much the anaerobic performance of individuals who experienced fatigue with Want (Wingate) affected their postural sway parameters.

Description:

The postural sway parameters of the individuals will be evaluated using the "Kistler Force Plate" and the anaerobic values will be evaluated using the Wingate Anaerobic Strength Test and the "Excalibur Sport Ergometer" device. The data obtained will be compared with the data of patients with and without Covid-19 disease using appropriate statistical methods.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 56
• Est. completion date: June 20, 2022
• Est. primary completion date: June 10, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years to 30 Years

Eligibility

Inclusion Criteria:

• Being between the ages of 18-30, - Being a volunteer - Having had Covid 19 in the last 3 month

Exclusion Criteria:

• Presence of neurologic and oncologic disease - Presence of orthopedic surgery - Presence of active Covid 19 disease - Any cardiopulmonary disease

Related Conditions & MeSH terms

• COVID-19
• Performance

Intervention

Diagnostic Test:
• Neuromuscular fatigue and postural sway evaluation
Neuromuscular fatigue will be established by using the Excalibur Sport Ergometer device and the Wingate Anaerobic Strength Test. Postural sway will be evaluated with Cyst Force Plate Balance device. This device is a precision device that provides objective measurable data.

Locations

Country	Name	City	State
Turkey	Karamanoglu Mehmetbey University	Karaman
Turkey	Karamanoglu Mehmetbey University	Karaman

Sponsors (1)

Lead Sponsor	Collaborator
Karamanoglu Mehmetbey University

Country where clinical trial is conducted

Turkey, 

References & Publications (1)

Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, Pujol JC, Klaser K, Antonelli M, Canas LS, Molteni E, Modat M, Jorge Cardoso M, May A, Ganesh S, Davies R, Nguyen LH, Drew DA, Astley CM, Joshi AD, Merino J, Tsereteli N, Fall T, Gomez MF, Duncan EL, Menni C, Williams FMK, Franks PW, Chan AT, Wolf J, Ourselin S, Spector T, Steves CJ. Attributes and predictors of long COVID. Nat Med. 2021 Apr;27(4):626-631. doi: 10.1038/s41591-021-01292-y. Epub 2021 Mar 10. Erratum in: Nat Med. 2021 Jun;27(6):1116. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Postural Sway	Postural sway will be evaluated with Cyst Force Plate Balance device. This device is a precision device that provides objectively measurable data. Thanks to its movable platform, it can measure in all directions. Participants will be asked to stand on the platform assessing their body oscillations. They will be asked to look at a still picture on the wall with their arms at the iliac and eyes directly opposite them. Individuals will be asked to keep their designated positions for 30 seconds. At the end of the specified period, the data obtained from the device will be saved. Before and after the neuromuscular fatigue test postural sway will be evaluated.	3 months